Subtle Cognitive Impairments in Patients with Long-Term Cure of Cushing’s Disease
The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Abstract
CONTEXT AND OBJECTIVE: Active Cushing's disease is associated with cognitive impairments. We hypothesized that previous hypercortisolism in patients with Cushing's disease results in irreversible impairments in cognitive functioning. Therefore, our aim was to assess cognitive functioning after long-term cure of Cushing's disease. DESIGN: Cognitive assessment consisted of 11 tests, which evaluated global cognitive functioning, memory, and executive functioning. PATIENTS AND CONTROL SUBJECTS: We included 74 patients cured of Cushing's disease and 74 controls matched for age, gender, and education. Furthermore, we included 54 patients previously treated for nonfunctioning pituitary macroadenomas (NFMA) and 54 controls matched for age, gender, and education. RESULTS: Compared with NFMA patients, patients cured from Cushing's disease had lower scores on the Mini Mental State Examination (P = 0.001), and on the memory quotient of the Wechsler Memory Scale (P = 0.050). Furthermore, patients cured from Cushing's disease tended to recall fewer words on the imprinting (P = 0.013), immediate recall (P = 0.012), and delayed recall (P = 0.003) trials of the Verbal Learning Test of Rey. On the Rey Complex Figure Test, patients cured from Cushing's disease had lower scores on both trials (P = 0.002 and P = 0.007) compared with NFMA patients. Patients cured from Cushing's disease also made fewer correct substitutions on the Letter-Digit Substitution Test (P = 0.039) and came up with fewer correct patterns on the Figure Fluency Test (P = 0.003) compared with treated NFMA patients. CONCLUSIONS: Cognitive function, reflecting memory and executive functions, is impaired in patients despite long-term cure of Cushing's disease. These observations indicate irreversible effects of previous hypercortisolism on cognitive function and, thus, on the central nervous system. These observations may also be of relevance for patients treated with high-dose exogenous glucocorticoids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Long-term effects of postnatal GC on the human brain include decreased memory and hippocampal volume (145), decreased cerebellar cortical volume (146), diminished cognitive function (147-149), increased psychopathology, and reduced QOL (148, 150)”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [149]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Studies of interference in serial verbal reactions
Stroop, J. R. (1935) · Journal of Experimental Psychology · doi:10.1037/h0054651 · Cited by 18,622
L'examen psychologique ; Dans les cas d'ence-phalopathie traumatique (Les problemes)
Rey, A. (1941) · Medical Entomology and Zoology · Cited by 3,330
Neuropsychological assessment.
Cipolotti, L., & Warrington, E. K. (1995) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.58.6.655 · Cited by 3,234
(1995) · Cited by 2,809
SPINHOVEN, P., ORMEL, J., SLOEKERS, P. P. A., KEMPEN, G. I. J. M., SPECKENS, A. E. M., & HEMERT, A. M. V. (1997) · Psychological Medicine · doi:10.1017/s0033291796004382 · Cited by 2,158 · cited 2×
“A total score higher than 13 points on both subscales together is used to characterize subjects as anxious or depressed (32, 33).”
BackgroundMcEwen, B. S. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.071 · Cited by 1,864 · cited 1×
“pocampus is one of the most sensitive structures in the brain for glucocorticoids and is crucial in cognitive function (37).”
BackgroundPost-Traumatic Stress Disorder
Yehuda, R. (2002) · New England Journal of Medicine · doi:10.1056/nejmra012941 · Cited by 1,134
Starkman, M. N., Gebarski, S. S., Berent, S., & Schteingart, D. E. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90079-f · Cited by 840 · cited 2×
“(11) reported that 27% of the patients with active Cushing’s syndrome fell outside the 95% confidence intervals for normal subject hippocampal formation volume and that hippocampal formation volume and performance on cognitive tests were positively related.”
Background
Research works printed but not linked: 5
- Wechsler, 1945, Wechsler Memory Scale
- Rey, 1958, L’examin Clinique en Psyhcologie
- Rey, 1941, L’examen psychologique dans les cas d’encephalopathie traumatique, Arch Psychol, 28, 286
- Reitan, 1956, Trail making test: manual for administration, scoring, and interpretation
- Luteijn, 1983, Manual Groninger Intelligence Test
Cited by
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Treatment of Cushing's syndrome: an Endocrine Society clinical practice guideline
Nieman, L. K., Biller, B. M. K., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., & Tabarin, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1818 · Cited by 1,270
“Deficits also occur in attention, visuospatial abilities, and working memory (185).”
BackgroundResultSpeiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
The Treatment of Cushing's Disease
Pivonello, R., De Leo, M., Cozzolino, A., & Colao, A. (2015) · Endocrine Reviews · doi:10.1210/er.2013-1048 · Cited by 465
Feelders, R. A., Pulgar, S. J., Kempel, A., & Pereira, A. M. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1095 · Cited by 256
Self-citationChornenkyy, Y., Wang, W., Wei, A., & Nelson, P. T. (2019) · Brain Pathology · doi:10.1111/bpa.12655 · Cited by 184
Neuropsychiatric disorders in Cushing's syndrome
Pivonello, R., Simeoli, C., De Martino, M. C., Cozzolino, A., De Leo, M., Iacuaniello, D., Pivonello, C., Negri, M., Pellecchia, M. T., Iasevoli, F., et al. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00129 · Cited by 174
“…impairments were reported in many domains of cognitive function including attention, visuospatial orienting, alerting, reasoning, working and speed memory, verbal fluency, reading, and executive functions (Forget et al., 2002; Tiemensma et al., 2010; Ragnarsson et al., 2012; Resmini et al., 2012).”
BackgroundNeuropsychiatric Disorders in Cushing’s Syndrome
Pereira, A. M., Tiemensma, J., & Romijn, J. A. (2010) · Neuroendocrinology · doi:10.1159/000314317 · Cited by 145
“Finally, patients cured of Cushing’s disease also made fewer correct substitutions (on the Letter-Digit Substitution Test) and came up with fewer correct patterns (on the Figure Fluency Test) compared with treated NFMA patients (18).”
ResultSelf-citationCushing’s disease: the burden of illness
Pivonello, R., De Martino, M. C., De Leo, M., Simeoli, C., & Colao, A. (2017) · Endocrine · doi:10.1007/s12020-016-0984-8 · Cited by 171
“The authors concluded that the effects on the central nervous system are irreversible and most likely explained by previous glucocorticoid excess [50].”
BackgroundResultInfluentialAndela, C. D., van Haalen, F. M., Ragnarsson, O., Papakokkinou, E., Johannsson, G., Santos, A., Webb, S. M., Biermasz, N. R., van der Wee, N. J. A., & Pereira, A. M. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-1101 · Cited by 164
Self-citationResmini, E., Santos, A., Gómez-Anson, B., Vives, Y., Pires, P., Crespo, I., Portella, M. J., de Juan-Delago, M., Barahona, M.-J., & Webb, S. M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2231 · Cited by 133
Ragnarsson, O., Berglund, P., Eder, D. N., & Johannsson, G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1945 · Cited by 111
“Recently, memory and executive functions were found to be impaired in patients with CD in long-term remission (11, 12).”
BackgroundComorbidities in Cushing’s disease
Sharma, S. T., Nieman, L. K., & Feelders, R. A. (2015) · Pituitary · doi:10.1007/s11102-015-0645-6 · Cited by 101
Andela, C. D., van der Werff, S. J. A., Pannekoek, J. N., van den Berg, S. M., Meijer, O. C., van Buchem, M. A., Rombouts, S. A. R. B., van der Mast, R. C., Romijn, J. A., Tiemensma, J., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0471 · Cited by 102
Self-citationvan Haalen, F. M., Broersen, L. H. A., Jorgensen, J. O., Pereira, A. M., & Dekkers, O. M. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0556 · Cited by 103
Self-citationWagenmakers, M. A. E. M., Netea-Maier, R. T., Prins, J. B., Dekkers, T., den Heijer, M., & Hermus, A. R. M. M. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0308 · Cited by 101
Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification
Asa, S. L., Mete, Ö., Cusimano, M. D., McCutcheon, I. E., Perry, A., Yamada, S., Nishioka, H., Casar‐Borota, O., Uccella, S., Rosa, S. L., et al. (2021) · Modern Pathology · doi:10.1038/s41379-021-00820-y · Cited by 100
van der Werff, S. J. A., Andela, C. D., Nienke Pannekoek, J., Meijer, O. C., van Buchem, M. A., Rombouts, S. A. R. B., van der Mast, R. C., Biermasz, N. R., Pereira, A. M., & van der Wee, N. J. A. (2014) · NeuroImage: Clinical · doi:10.1016/j.nicl.2014.01.017 · Cited by 92
“In a previous study from our group, it was demonstrated that patients with longterm remission of Cushing’s disease demonstrate subtle cognitive impairments (Tiemensma et al., 2010b).”
BackgroundResultSelf-citationToward a Diagnostic Score in Cushing's Syndrome
Braun, L. T., Riester, A., Oßwald-Kopp, A., Fazel, J., Rubinstein, G., Bidlingmaier, M., Beuschlein, F., & Reincke, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00766 · Cited by 81
“Cognitive changes Prevalence unclear, but cognitive impairments are frequent even over the long-term (37) Unclear”
BackgroundTiemensma, J., Kaptein, A. A., Pereira, A. M., Smit, J. W. A., Romijn, J. A., & Biermasz, N. R. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0307 · Cited by 87
“This relationship is a relevant observation, since patients with long-term cure of Cushing’s syndrome have persistent complaints reflected in impaired QoL (3-5).”
BackgroundSelf-citationNieman, L. K., Castinetti, F., Newell-Price, J. D. C., Valassi, E., Drouin, J., Takahashi, Y., & Lacroix, A. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00588-w · Cited by 91
“…patients with CD or those with adrenal adenomas who are in remission have persistent subtle cognitive impairment, including deficits in memory, attention and executive function, and altered affectivity (mainly anxiety, depressive symptoms, negative affect and impaired stress responsivity) 235,236 .”
Psychiatric and neurocognitive consequences of endogenous hypercortisolism
Piasecka, M., Papakokkinou, E., Valassi, E., Vives, A. S., Webb, S. M., de Vries, F., Pereira, A. M., & Ragnarsson, Ó. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13056 · Cited by 79
Self-citationCoping Strategies in Patients after Treatment for Functioning or Nonfunctioning Pituitary Adenomas
Tiemensma, J., Kaptein, A. A., Pereira, A. M., Smit, J. W. A., Romijn, J. A., & Biermasz, N. R. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2490 · Cited by 72
“Patients after long-term remission of Cushing’s disease suffer from subtle cognitive impairments, increased prevalence of psychopathology, and an increased incidence of maladaptive personality traits (7, 15).”
BackgroundSelf-citationAndela, C. D., Niemeijer, N. D., Scharloo, M., Tiemensma, J., Kanagasabapathy, S., Pereira, A. M., Kamminga, N. G. A., Kaptein, A. A., & Biermasz, N. R. (2014) · Pituitary · doi:10.1007/s11102-014-0561-1 · Cited by 74
“The diagnosis and state of biochemical remission were confirmed in all patients, following previously described criteria [7, 39–41].”
ResultSelf-citationTiemensma, J., Biermasz, N. R., van der Mast, R. C., Wassenaar, M. J. E., Middelkoop, H. A. M., Pereira, A. M., & Romijn, J. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1253 · Cited by 72
“Present study Acromegaly: 68 Matched controls: 68 NFMA: 60 Matched controls: 60 35/33 59 11 Controlled (68) Surgery (68) RT (15) SMS (11) Duration of remission 13 8 yr Apathy Scale, Irritability Scale, HADS, MASQ30, DAPPs, MMSE, WMS, VLTR, RCFT, TMT, SCWT, LDST, DDT, FFT, FAS, GITsynonyms Patients with long-term cure…”
BackgroundInfluentialSelf-citationBrummelman, P., Elderson, M. F., Dullaart, R. P. F., van den Bergh, A. C. M., Timmer, C. A., van den Berg, G., Koerts, J., Tucha, O. M., Wolffenbuttel, B. H. R., & van Beek, A. P. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03947.x · Cited by 66
Biermasz, N. R., Joustra, S. D., Donga, E., Pereira, A. M., van Duinen, N., van Dijk, M., van der Klaauw, A. A., Corssmit, E. P. M., Lammers, G. J., van Kralingen, K. W., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2742 · Cited by 67
“073 Years after surgery, median (range) 8 (1-18)”
MethodSelf-citationAnderson, R. M., Glanz, R. M., Johnson, S. B., Miller, M. M., Romig‐Martin, S. A., & Radley, J. J. (2016) · Journal of Comparative Neurology · doi:10.1002/cne.24027 · Cited by 61
Clinical consequences of Cushing’s syndrome
Valassi, E., Crespo, I., Vives, A. S., & Webb, S. M. (2012) · Pituitary · doi:10.1007/s11102-012-0394-8 · Cited by 65
“Hypopituitarism and hydrocortisone dependency were significant predictors of poor performance on some cognitive tests [51].”
BackgroundSmall cerebellar cortex volume in patients with active Cushing’s syndrome
Santos, A., Resmini, E., Crespo, I., Pires, P., Vives-Gilabert, Y., Granell, E., Valassi, E., Gómez-Anson, B., Martínez-Momblán, M. A., Mataró, M., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0371 · Cited by 60
Resting-State Functional Connectivity in Patients with Long-Term Remission of Cushing’s Disease
van der Werff, S. J. A., Pannekoek, J. N., Andela, C. D., Meijer, O. C., van Buchem, M. A., Rombouts, S. A. R. B., van der Mast, R. C., Biermasz, N. R., Pereira, A. M., & van der Wee, N. J. A. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.38 · Cited by 60
“After successful biochemical treatment of Cushing’s disease, psychiatric symptoms decrease, but patients still show cogni¬tive impairment (Dorn and Cerrone, 2000; Forget et al., 2002; Merke et al., 2005; Tiemensma et al., 2010b; Resmini et al., 2012), decreased quality of life (Tiemensma et al.”
BackgroundInfluentialSelf-citationPituitary adenomas and neuropsychological status: a systematic literature review
Pertichetti, M., Serioli, S., Belotti, F., Mattavelli, D., Schreiber, A., Cappelli, C., Padovani, A., Gasparotti, R., Nicolai, P., Fontanella, M. M., et al. (2019) · Neurosurgical Review · doi:10.1007/s10143-019-01134-z · Cited by 60
Impaired decision‐making and selective cortical frontal thinning in Cushing's syndrome
Crespo, I., Esther, G., Santos, A., Valassi, E., Yolanda, V., De Juan‐Delago, M., Webb, S. M., Gómez‐Ansón, B., & Resmini, E. (2014) · Clinical Endocrinology · doi:10.1111/cen.12564 · Cited by 54
Bou Khalil, R., Baudry, C., Guignat, L., Carrasco, C., Guibourdenche, J., Gaillard, S., Bertagna, X., & Bertherat, J. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0424 · Cited by 58
Ragnarsson, O., & Johannsson, G. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0534 · Cited by 51
Frimodt-Møller, K. E., Jepsen, J. R. M., Feldt‐Rasmussen, U., & Krogh, J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00749 · Cited by 56
Long-term consequences of Cushing syndrome: a systematic literature review
Puglisi, S., Perini, A. M. E., Botto, C., Oliva, F., & Terzolo, M. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad453 · Cited by 53
Quality of Life in Patients With Cushing's Disease
Vives, A. S., Resmini, E., Martínez-Momblán, M.-A., Valassi, E., Martel‐Duguech, L., & Webb, S. M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00862 · Cited by 78
“This has been found 1 year after biochemical cure (85, 86), 3 years after surgery for CS (9) and also in patients with long-term remission, with lower scores when compared to healthy controls and non-functioning adenomas (6, 82, 87, 88).”
BackgroundHippocampal dysfunction in cured Cushing's syndrome patients, detected by 1H‐MR‐spectroscopy
Resmini, E., Santos, A., Gómez‐Anson, B., López‐Mourelo, O., Pires, P., Vives‐Gilabert, Y., Crespo, I., Portella, M. J., de Juan‐Delago, M., & Webb, S. M. (2013) · Clinical Endocrinology · doi:10.1111/cen.12224 · Cited by 48
Glad, C. A. M., Andersson-Assarsson, J. C., Berglund, P., Bergthorsdottir, R., Ragnarsson, O., & Johannsson, G. (2017) · Scientific Reports · doi:10.1038/srep44445 · Cited by 43
The burden of disease for pituitary patients
Biermasz, N. R. (2019) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2019.101309 · Cited by 47
Self-citationAltered neural processing of emotional faces in remitted Cushing's disease
Bas-Hoogendam, J. M., Andela, C. D., van der Werff, S. J. A., Pannekoek, J. N., van Steenbergen, H., Meijer, O. C., van Buchem, M. A., Rombouts, S. A. R. B., van der Mast, R. C., Biermasz, N. R., et al. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.05.001 · Cited by 44
Self-citationLong-term cognitive effects of glucocorticoid excess in Cushing’s syndrome
Forget, H., Lacroix, A., Bourdeau, I., & Cohen, H. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.11.020 · Cited by 53
Andela, C. D., Scharloo, M., Ramondt, S., Tiemensma, J., Husson, O., Llahana, S., Pereira, A. M., Kaptein, A. A., Kamminga, N. G. A., & Biermasz, N. R. (2016) · Pituitary · doi:10.1007/s11102-016-0707-4 · Cited by 44
“Details on diagnostic criteria and criteria for remission and follow-up have been previously described: CD [16], ACRO [3], PRL [5], NFA [17].”
Self-citationCristante, J., Lefournier, V., Sturm, N., Passagia, J. G., Gauchez, A. S., Tahon, F., Cantin, S., Chabre, O., & Gay, E. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00333 · Cited by 39
Broersen, L. H. A., Andela, C. D., Dekkers, O. M., Pereira, A. M., & Biermasz, N. R. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01054 · Cited by 42
Self-citationQuality of Life and Other Outcomes in Children Treated for Cushing Syndrome
Keil, M. F. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1123 · Cited by 45
Cardiovascular risk and white matter lesions after endocrine control of Cushing's syndrome
Santos, A., Resmini, E., Gómez-Ansón, B., Crespo, I., Granell, E., Valassi, E., Pires, P., Vives-Gilabert, Y., Martínez-Momblán, M. A., de Juan, M., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0600 · Cited by 37
Andela, C. D., Lobatto, D. J., Pereira, A. M., van Furth, W. R., & Biermasz, N. R. (2018) · Pituitary · doi:10.1007/s11102-017-0860-4 · Cited by 45
“Previous studies demonstrated that patients treated for NFA had a worse performance on verbal memory and executive functioning compared to healthy matched controls and references values [30, 31].”
BackgroundSelf-citationValassi, E., Crespo, I., Keevil, B. G., Aulinas, A., Urgell, E., Vives, A. S., Trainer, P. J., & Webb, S. M. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0779 · Cited by 46
Psychiatric Symptoms in Cushing's Syndrome: A Systematic Review.
Vaccarino, A. L., Kalali, A. H., Blier, P., Evans, S. G., Engelhardt, N., Foster, J. A., Frey, B. N., Greist, J. H., Kobak, K. A., Lam, R. W. M., et al. (2020) · PubMed Central · Cited by 73
Brummelman, P., Sattler, M. G. A., Meiners, L. C., Elderson, M. F., Dullaart, R. P. F., van den Berg, G., Koerts, J., Tucha, O. M., Wolffenbuttel, B. H. R., den Bergh, A. C. M. V., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0749 · Cited by 39
“For our study, we used a homogeneous patient group of patients with NFA, thereby excluding confounding results by excess hormone or other treatment-related factors [34].”
MethodCollaer, M. L., Hindmarsh, P. C., Pasterski, V., Fane, B. A., & Hines, M. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.11.010 · Cited by 38
Mild cognitive deficits in patients with primary adrenal insufficiency
Tiemensma, J., Andela, C. D., Biermasz, N. R., Romijn, J. A., & Pereira, A. M. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.09.029 · Cited by 40
“In line with these observations, a direct comarison of the cognitive performance of patients with PAI in the resent study, with cognitive functioning of patients in long-term emission of CD (data derived from a previous study by our research roup (Tiemensma et al., 2010)) revealed that patients with PAI and atients in…”
BackgroundResultSelf-citationMorbidity of Cushing’s Syndrome and Impact of Treatment
Webb, S. M., & Valassi, E. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2018.01.001 · Cited by 42
Athanasoulia, A. P., Ising, M., Pfister, H., Mantzoros, C. S., Stalla, G. K., & Sievers, C. (2012) · Neuroendocrinology · doi:10.1159/000335996 · Cited by 36
Chan, L. F., Vaidya, M., Westphal, B., Allgrove, J., Martin, L., Afshar, F., Hindmarsh, P. C., Savage, M. O., Grossman, A. B., & Storr, H. L. (2011) · Hormone Research in Paediatrics · doi:10.1159/000324419 · Cited by 37
“The general consensus view in adult patients is that quality of life following CD may be permanently impaired despite biochemical cure. In support of this, a recent study demonstrated long-term persistent cognitive deficiencies and increased prevalence of psychopathology in adult patients with cured CD [”
ResultSarabdjitsingh, R. A., Spiga, F., Oitzl, M. S., Kershaw, Y., Meijer, O. C., Lightman, S. L., & De Kloet, E. R. (2010) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2010.02004.x · Cited by 35
Tiemensma, J., Daskalakis, N. P., van der Veen, E. M., Ramondt, S., Richardson, S. K., Broadbent, E., Romijn, J. A., Pereira, A. M., Biermasz, N. R., & Kaptein, A. A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1235 · Cited by 38
Self-citationMental Fatigue and Executive Dysfunction in Patients with Cushing’s Syndrome in Remission
Papakokkinou, E., Johansson, B., Berglund, P., & Ragnarsson, O. (2015) · Behavioural Neurology · doi:10.1155/2015/173653 · Cited by 29
“Compared to patients treated for nonfunctioning pituitary adenomas, patients with CD in remission perform worse in certain aspects of executive functioning and memory and report a higher prevalence of psychopathology [6, 16].”
BackgroundWeber, D. C., Momjian, S., Pralong, F. P., Meyer, P., Villemure, J. G., & Pica, A. (2011) · Radiation Oncology · doi:10.1186/1748-717x-6-169 · Cited by 34
“The effect of radiation on patient’s cognitive function is however controversial, as patient with pituitary adenoma have suboptimal cognition (anterograde memory[41], verbal memory and executive functioning deficits[42,43]) when compared to normal controls.”
BackgroundStructural brain abnormalities in Cushing's syndrome
Bauduin, S., van der Wee, N. J. A., & van der Werff, S. J. A. (2018) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000414 · Cited by 37
Ragnarsson, O., Glad, C. A. M., Berglund, P., Bergthorsdottir, R., Eder, D. N., & Johannsson, G. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1906 · Cited by 33
“Cognitive function is impaired in patients successfully treated for Cushing’s syndrome (CS) (1, 2).”
BackgroundResmini, E., Vives, A. S., & Webb, S. M. (2016) · Frontiers of hormone research · doi:10.1159/000443868 · Cited by 36
Ragnarsson, Ó., Stomby, A., Dahlqvist, P. M., Evang, J. A., Ryberg, M., Olsson, T., Bollerslev, J., Nyberg, L. H., & Johannsson, G. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.05.010 · Cited by 31
Hou, B., Gao, L., Shi, L., Luo, Y., Guo, X., Young, G. S., Qin, L., Zhu, H., Lü, L., Wang, Z., et al. (2020) · Journal of neurosurgery · doi:10.3171/2019.10.jns191400 · Cited by 28
The chronic syndromes after previous treatment of pituitary tumours
Romijn, J. A. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.84 · Cited by 28
Self-citationLajić, S., Karlsson, L., & Nordenström, A. (2018) · Hormone Research in Paediatrics · doi:10.1159/000485100 · Cited by 32
Patient and Provider Perspectives on Postsurgical Recovery of Cushing Syndrome
Acree, R., Miller, C. M., Abel, B. S., Neary, N. M., Campbell, K. K., & Nieman, L. K. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab109 · Cited by 24
“However, reduction in HRQOL in CS despite biochemical remission is well established and our findings are in line with these previous reports (2, 4, 5, 7, 9-14, 21,22,29,41,42).”
ResultCrespo, I., Vives, A. S., Gómez‐Ansón, B., López‐Mourelo, O., Pires, P., Vives‐Gilabert, Y., Webb, S. M., & Resmini, E. (2016) · Endocrine · doi:10.1007/s12020-016-0963-0 · Cited by 28
Cases of Psychiatric Morbidity in Pediatric Patients After Remission of Cushing Syndrome
Keil, M. F., Zametkin, A. J., Ryder, C., Lodish, M. B., & Stratakis, C. A. (2016) · PEDIATRICS · doi:10.1542/peds.2015-2234 · Cited by 24
Neurocognitive changes in pituitary adenoma patients after Gamma Knife radiosurgery
Tooze, A., & Sheehan, J. P. (2018) · Journal of neurosurgery · doi:10.3171/2018.7.gks181595 · Cited by 23
Laura, E., Sosa, E., Nayeli, M., & Moisés, M. (2013) · Endocrine Practice · doi:10.4158/ep12247.or · Cited by 23
Syndromes de Cushing : physiopathologie, étiologie et principes thérapeutiques
Chabre, O. (2014) · La Presse Médicale · doi:10.1016/j.lpm.2014.02.001 · Cited by 21
“Cependant, il est maintenant établi qu’il n’y a pas de retour parfait à la normale, en termes de morbidité cardiovasculaire [52], de qualité de vie [6], de masse musculaire [53], de lithiase urinaire [54], de retentissement neuro-psychique sur les fonctions cognitives [55,56].”
Mild deficits in attentional control in patients with the IGSF 1 deficiency syndrome
Joustra, S. D., Andela, C. D., Oostdijk, W., van Trotsenburg, A. S. P., Fliers, E., Wit, J. M., Pereira, A. M., Middelkoop, H. A. M., & Biermasz, N. R. (2016) · Clinical Endocrinology · doi:10.1111/cen.12947 · Cited by 21
Self-citationPronóstico del paciente tratado de síndrome de Cushing
Aulinas, A., Valassi, E., & Webb, S. M. (2013) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2013.03.008 · Cited by 21
Beatriz Lecumberri, S., Estrada, J. S., García-Uría, J., Millán, I., Pallardo, L. F., Caballero, L., & Lúcas, T. (2015) · Pituitary · doi:10.1007/s11102-015-0653-6 · Cited by 22
“Furthermore, in 2010 it was revealed that subtle memory and executive function impairments were present in patients with long-term cure of CD [27], but not of AC [28], and that psycholopathology and maladaptive personality traits were increased after long-term cure of both CD and AC [28].”
BackgroundFunctional brain alterations in Cushing’s syndrome
Papakokkinou, E., & Ragnarsson, Ó. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1163482 · Cited by 20
“Unfortunately, despite treatment, patients with CS still have impaired memory and executive function, in comparison to healthy controls, as well as when compared with patients treated for nonfunctioning pituitary macroadenomas (11).”
BackgroundResultThe impact of transsphenoidal surgery on neurocognitive function: A systematic review
Alsumali, A., Coté, D. J., Regestein, Q. R., Crocker, E., Alzarea, A. I., Zaidi, H. A., Bi, W. L., Dawood, H. Y., Broekman, M. L. D., van Zandvoort, M. J. E., et al. (2017) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2017.01.015 · Cited by 19
“Regarding specific pituitary tumors, patients treated for Cushing’s disease were reported to have a decline in both immediate and delayed recall on the Auditory Verbal Learning Test [8].”
InfluentialCortical thickness abnormalities in long-term remitted Cushing’s disease
Bauduin, S., van der Pal, Z., Pereira, A. M., Meijer, O. C., Giltay, E. J., van der Wee, N. J. A., & van der Werff, S. J. A. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00980-6 · Cited by 18
Self-citationStomby, A., Salami, A., Dahlqvist, P. M., Evang, J. A., Ryberg, M., Bollerslev, J., Olsson, T., Johannsson, G., & Ragnarsson, Ó. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0028 · Cited by 19
Galiana, P. A., Fajardo, C., Suárez, P. A. R., Gómez-Vela, J., Escrivá, C., & Rovira-Lillo, V. (2012) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2012.09.009 · Cited by 18
Butterbrod, E., Gehring, K., Voormolen, E. H. J., Depauw, P. R. A. M., Nieuwlaat, W., Rutten, G.-J. M., & Sitskoorn, M. M. (2019) · Journal of neurosurgery · doi:10.3171/2019.5.jns19595 · Cited by 18
Cushing Disease Presenting as Primary Psychiatric Illness: A Case Report and Literature Review
Rasmussen, S. A., Rosebush, P. I., Smyth, H. S., & Mazurek, M. F. (2015) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000113 · Cited by 22
Glucocorticoid Regulation of Food-Choice Behavior in Humans: Evidence from Cushing's Syndrome
Moeller, S. J., Couto, L., Cohen, V. V., Lalazar, Y., Makotkine, I., Williams, N., Yehuda, R., Goldstein, R. Z., & Geer, E. B. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00021 · Cited by 18
Psychological well-being and illness perceptions in patients with hypopituitarism
Slagboom, T. N. A., Deijen, J. B., van Bunderen, C. C., Knoop, H., & Drent, M. L. (2021) · Pituitary · doi:10.1007/s11102-021-01131-w · Cited by 16
Characterization of persistent and recurrent Cushing’s disease
Sundaram, N. K., Carluccio, A. L., & Geer, E. B. (2013) · Pituitary · doi:10.1007/s11102-013-0511-3 · Cited by 19
“In addition, sustained neuropsychiatric abnormalities such as impairments of memory and language performance, as well as persistence of depression, anxiety, and mania is well documented in patients after resolution of hypercortisolism [84–87].”
BackgroundDysregulation of resting-state functional connectivity in patients with Cushing’s disease
Wang, X., Zhou, T., Wang, P., Zhang, L., Feng, S., Meng, X., Yu, X., & Zhang, Y. (2019) · Neuroradiology · doi:10.1007/s00234-019-02223-y · Cited by 16
Neuropsychological and Emotional Functioning in Patients with Cushing’s Syndrome
Na, S. D., Fernandes, M. A., Ioachimescu, A. G., & Penna, S. (2020) · Behavioural Neurology · doi:10.1155/2020/4064370 · Cited by 16
Predictors of long-term remission after transsphenoidal surgery in Cushing's disease
Galiana, P. A., Fajardo, C., Suárez, P. A. R., Gómez-Vela, J., Escrivá, C., & Rovira-Lillo, V. (2013) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2013.10.002 · Cited by 17
Crouzeix, G., Morello, R., Thariat, J., Morera, J., Joubert, M., & Reznik, Y. (2019) · Hormone and Metabolic Research · doi:10.1055/a-0850-9448 · Cited by 15
“Study strengths relate to the exclusion from the study of patients with secreting pituitary adenomas, thus avoiding possible biases related to the impact of endocrine disturbances on cognitive function and QoL [24, 36].”
BackgroundSleurs, C., Fletcher, P. C., Mallucci, C. L., Avula, S., & Ajithkumar, T. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-023-01096-9 · Cited by 13
“Furthermore, long-term hypercortisolism (i.e. endogenous cortisol) as well as cortisol replacement (e.g. exogenous cortisol) can potentially lead to decreased memory performance [78].”
BackgroundRoelfsema, F., Pereira, A. M., Biermasz, N. R., & Veldhuis, J. D. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2363 · Cited by 13
“Remission criteria for Cushing’s disease are 24-hour urinary free cortisol excretion less than 220 nmol and a 1-mg dexamethasone-suppressed serum cortisol concentration below 100 nmol/L (19).”
BackgroundSelf-citationGao, L., Liu, L., Shi, L., Luo, Y., Wang, Z., Guo, X., & Xing, B. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09540-1 · Cited by 11
Neuropsychological functioning in patients with Cushing’s disease and Cushing’s syndrome
Siegel, S., Kirstein, C. F., Grzywotz, A., Hütter, B. O., Wrede, K. H., Kuhna, V., & Kreitschmann-Andermahr, I. (2021) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1247-4651 · Cited by 10
Challenges in the postsurgical recovery of cushing syndrome: glucocorticoid withdrawal syndrome
Zhang, C. D., & Ioachimescu, A. G. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1353543 · Cited by 13
van Trigt, V. R., Andela, C. D., Bakker, L. E. H., Brama, S. C. M., Schmidt, L. E., Sneekes, F. M., Zeelenberg, M. W., Huisman, S. D., Bauduin, S., Dekkers, O. M., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf355 · Cited by 10
Self-citationHypothalamo-Pituitary-Adrenal Axis in Depressive Disorders and Treatment Resistance
Yunilaynen, O. A., Starostina, E. G., & Oleichik, I. V. (2023) · Psikhiatriya · doi:10.30629/2618-6667-2023-21-1-73-90 · Cited by 10
Cognitive decline in Cushing's syndrome: A systematic review
Katragadda, A., Kunadia, J., Kirsch, P. M., Dorcely, B., Shah, S., Henig, Z., Job, A., Feelders, R. A., & Agrawal, N. (2024) · Journal of Neuroendocrinology · doi:10.1111/jne.13466 · Cited by 12
“46 Dorn et al. found that lower morning baseline cortisol levels (abnormal cortisol response of less than 18 μ g/dL after a morning ACTH stimulation test) 6 – 12 months post-operatively were related to greater numbers of persistent symptoms.”
Prognosis of patients treated for Cushing syndrome
Aulinas, A., Valassi, E., & Webb, S. M. (2014) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2014.01.004 · Cited by 13
Metadata
- Authors
- Tiemensma, J., Kokshoorn, N. E., Biermasz, N. R., Keijser, B.-J. S. A., Wassenaar, M. J. E., Middelkoop, H. A. M., Pereira, A. M., & Romijn, J. A.
- Affiliations
- Leiden University Medical Center (NL)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2010-06-01
- Volume
- 95
- Issue
- 6
- Pages
- 2699-2714
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2001003028
- Cited by
- 159
- References
- 41
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 9 · 2023: 6 · 2022: 8 · 2021: 8 · 2020: 9 · 2019: 12 · 2018: 14 · 2017: 5 · 2016: 15 · 2015: 18 · 2014: 10 · 2013: 12 · 2012: 9
- FWCI
- 8.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- Cushing's disease, hypercortisolism, cognitive impairment, memory impairment, executive function, long-term cure, non-functioning pituitary macroadenoma, verbal learning, visuospatial ability
- MeSH terms
- Adult, Aged, Anxiety, Cognition Disorders, Depression, Female, Humans, Male, Memory, Memory, Short-Term, Middle Aged, Neuropsychological Tests, Pituitary Function Tests, Psychiatric Status Rating Scales, Wechsler Scales, Treatment Outcome, Survivors, Pituitary ACTH Hypersecretion, ACTH-Secreting Pituitary Adenoma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.